表紙：癌患者外来輸液の市場規模・シェア・産業分析 (2022-2030年)：製品・用途・療法・モード・地域別の展望・成長の潜在性・競合市場シェア・予測

市場調査レポート

商品コード

1081218

癌患者外来輸液の市場規模・シェア・産業分析 (2022-2030年)：製品・用途・療法・モード・地域別の展望・成長の潜在性・競合市場シェア・予測

Outpatient Oncology Infusion Market Size, Share and Industry Analysis Report by Product, Application, By Therapy and Mode (Intramuscular, Intravenous, Subcutaneous), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2030

出版日: 2022年05月09日 | 発行: Global Market Insights Inc.

| ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 4,850 760,286円

レポートPDFおよびExcelを1名様のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Multi User License)

USD 5,350 838,666円

レポートPDFおよびExcelを5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 8,350 1,308,946円

レポートPDFおよびExcelを同一企業内のすべての方にご利用頂けるライセンスです。 100％子会社は同一企業とみなされます。 PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の癌患者外来輸液の市場は、癌患者数の増加や、癌治療のR&Dに対する世界的な関心の高まりから、2030年にかけて目覚ましい成長を遂げると予想されています。

製品別で見ると、IVカニューレの部門が2021年に約40億米ドルの収益規模を示しています。これは、治験医療プロセスにおける薬剤の注入または血液サンプルの採取のためにIVカニューレの採用が増加していることが主な理由です。また、療法別では、世界の癌の有病率の上昇を背景に、ホルモン療法の部門が2021年に60億米ドル超の規模を示しています。また、ホルモン療法のような代替癌治療の利点に関する患者や医師の意識の高まりも産業の成長を推進する主要な成長要因です。

当レポートでは、世界の癌患者外来輸液の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

Data Tables

TABLE 1 Outpatient oncology infusion industry 360 degree synopsis, 2017-2030
TABLE 2 Global outpatient oncology infusion market, 2017-2030 (USD Million)
TABLE 3 Global outpatient oncology infusion market, by product, 2017-2030 (USD Million)
TABLE 4 Global outpatient oncology infusion market, by application, 2017-2030 (USD Million)
TABLE 5 Global outpatient oncology infusion market, by therapy, 2017-2030 (USD Million)
TABLE 6 Global outpatient oncology infusion market, by mode, 2017-2030 (USD Million)
TABLE 7 Global outpatient oncology infusion market, by region, 2017-2030 (USD Million)
TABLE 8 Industry impact forces
TABLE 9 Infusion pumps market size, by region, 2017-2030 (USD Million)
TABLE 10 Intravenous sets market size, by region, 2017-2030 (USD Million)
TABLE 11 IV cannulas market size, by region, 2017-2030 (USD Million)
TABLE 12 Needleless connectors market size, by region, 2017-2030 (USD Million)
TABLE 13 Lung cancer market size, by region, 2017-2030 (USD Million)
TABLE 14 Liver cancer market size, by region, 2017-2030 (USD Million)
TABLE 15 Breast cancer market size, by region, 2017-2030 (USD Million)
TABLE 16 Prostate cancer market size, by region, 2017-2030 (USD Million)
TABLE 17 Others market size, by region, 2017-2030 (USD Million)
TABLE 18 Chemotherapy market size, by region, 2017-2030 (USD Million)
TABLE 19 Targeted therapy market size, by region, 2017-2030 (USD Million)
TABLE 20 Immunotherapy market size, by region, 2017-2030 (USD Million)
TABLE 21 Hormonal therapy market size, by region, 2017-2030 (USD Million)
TABLE 22 Intramuscular (IM) market size, by region, 2017-2030 (USD Million)
TABLE 23 Intravenous (IV) market size, by region, 2017-2030 (USD Million)
TABLE 24 Others market size, by region, 2017-2030 (USD Million)
TABLE 25 North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 26 North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 27 North America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 28 North America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 29 North America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 30 North America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 31 U.S. outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 32 U.S. outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 33 U.S. outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 34 U.S. outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 35 Canada outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 36 Canada outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 37 Canada outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 38 Canada outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 39 Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 40 Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 41 Europe outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 42 Europe outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 43 Europe outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 44 Europe outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 45 Germany outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 46 Germany outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 47 Germany outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 48 Germany outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 49 UK outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 50 UK outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 51 UK outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 52 UK outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 53 France outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 54 France outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 55 France outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 56 France outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 57 Spain outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 58 Spain outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 59 Spain outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 60 Spain outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 61 Italy outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 62 Italy outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 63 Italy outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 64 Italy outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 65 Asia Pacific outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 66 Asia Pacific outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 67 Asia Pacific outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 68 Asia Pacific outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 69 Asia Pacific outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 70 Japan outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 71 Japan outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 72 Japan outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 73 Japan outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 74 China outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 75 China outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 76 China outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 77 China outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 78 India outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 79 India outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 80 India outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 81 India outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 82 Australia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 83 Australia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 84 Australia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 85 Australia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 86 Latin America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 87 Latin America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 88 Latin America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 89 Latin America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 90 Latin America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 91 Brazil outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 92 Brazil outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 93 Brazil outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 94 Brazil outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 95 Mexico outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 96 Mexico outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 97 Mexico outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 98 Mexico outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 99 MEA outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
TABLE 100 MEA outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 101 MEA outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 102 MEA outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 103 MEA outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 104 South Africa outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 105 South Africa outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 106 South Africa outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 107 South Africa outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 108 Saudi Arabia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 109 Saudi Arabia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 110 Saudi Arabia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 111 Saudi Arabia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
TABLE 112 UAE outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
TABLE 113 UAE outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
TABLE 114 UAE outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
TABLE 115 UAE outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

Charts & Figures

FIG. 1 Industry segmentation
FIG. 2 Global outpatient oncology infusion market, 2017 - 2030 (USD Million)
FIG. 3 Growth potential analysis, by product
FIG. 4 Growth potential analysis, by application
FIG. 5 Growth potential analysis, by therapy
FIG. 6 Growth potential analysis, by mode
FIG. 7 Porter's analysis
FIG. 8 PESTEL analysis
FIG. 9 Key segment trends, by product
FIG. 10 Key segment trends, by application
FIG. 11 Key segment trends, by therapy
FIG. 12 Key segment trends, by mode
FIG. 13 Key regional trends
FIG. 14 Strategy dashboard, 2021

Product Code: 5268

The global outpatient oncology infusion market is expected to register commendable growth by 2030, due in part to the rising prevalence of cancer cases and growing investment interest towards R&D for cancer treatment worldwide.

Outpatient oncology infusion therapy is rapidly emerging as a major component of modern cancer treatment protocols. Infusion therapy refers to procedures where medicine is administered directly into the bloodstream of the patient to shrink or curb the growth of cancer cells.

Outpatient infusion therapies for cancer treatment encompass various services, including hormone therapy, immunotherapy, chemotherapy, and blood transfusions, as well as other infusion treatments the patient may require, like antibiotics, pain medication, and hydration fluids.

The global outpatient oncology infusion market is bifurcated in terms of product, application, therapy, mode, and region.

With respect to product, the outpatient oncology infusion industry is further classified into intravenous sets, infusion pumps, needleless connectors, and IV cannulas.

Of these, the IV cannulas segment registered revenues worth nearly $4 billion in 2021. This was credited largely to a rising adoption of IV cannulas for the infusion of medication or collection of blood samples in investigational medical processes.

Based on application, the outpatient oncology infusion market is segregated into liver cancer, lung cancer, prostate cancer, breast cancer, and others.

The liver cancer segment held a 3.9% share of the overall market in 2021, given the rapid rise in the prevalence of liver cancer, as well as the escalating demand for infusion therapies like targeted therapy or immunotherapy.

In February 2022, for instance, oncologists and surgeons at Penn Medicine's Department of Surgery used adjuvant hepatic artery infusion chemotherapy along with systemic chemotherapy, in order to treat unresectable CLMs (colorectal liver metastases) or mitigate the risk of recurrence among individuals with resected CLMs.

From a therapy perspective, the outpatient oncology infusion industry is categorized into targeted therapy, immunotherapy, chemotherapy, and hormonal therapy. The hormonal therapy segment recorded a remuneration of over $6 billion in 2021, driven by the growing prevalence of cancer across the globe.

Additionally, rising awareness among patients and physicians regarding the benefits of alternative cancer treatments like hormone therapy is a major driver propelling industry growth.

With regard to mode, the overall outpatient oncology infusion market is divided into Intravenous (IV), Intramuscular (IM), Subcutaneous, and other.

In 2021, the intravenous (IV) segment accounted for almost 30.6% of the overall market share due to the rising occurrence of lung cancer, wherein IV solutions act as the primary source of energy for the patients. In addition, increasing rollout of intravenous (IV) products has also elevated the industry outlook.

In March 2022, for instance, a new therapy was approved by the FDA for the treatment of advanced prostate cancer metastasizing within the body. Known as Pluvicto, the therapy was designed to be administered via intravenous infusion, to identify and destroy tumors too small to be noticed through conventional medical imaging techniques.

On the regional front, the Latin America outpatient oncology infusion industry is poised to register a 12.2% CAGR through the forecast time period. This growth is mainly credited to technological advancements in the regional medical domain, and strong market players focus on developing novel and sophisticated outpatient oncology infusion therapies.

Chapter 1 Methodology

1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
- 1.4.1 Secondary
  - 1.4.1.1 Paid sources
  - 1.4.1.2 Unpaid sources
- 1.4.2 Primary

Chapter 2 Executive Summary

2.1 Outpatient oncology infusion industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Therapy trends
- 2.1.5 Mode trends
- 2.1.6 Regional trends

Chapter 3 Outpatient Oncology Infusion Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Recent technological advancements in infusion pumps
  - 3.3.1.2 Rising prevalence of cancer across the globe
  - 3.3.1.3 Surging government initiatives for cancer awareness
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 High costs of cancer therapies
  - 3.3.2.2 Safety concern associated with the cancer therapy
3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By therapy
- 3.4.4 By mode
3.5 COVID-19 impact analysis
3.6 Porter's analysis
3.7 Competitive landscape, 2021
3.8 PESTEL analysis

Chapter 4 Outpatient Oncology Infusion Market, By Product

4.1 Key segment trends
4.2 Infusion Pumps
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Intravenous Sets
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 IV Cannulas
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.5 Needleless Connectors
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Outpatient Oncology Infusion Market, By Application

5.1 Key segment trends
5.2 Lung Cancer
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Liver Cancer
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Breast Cancer
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Prostate Cancer
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
5.6 Other
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Outpatient Oncology Infusion Market, By Therapy

6.1 Key segment trends
6.2 Chemotherapy
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Targeted Therapy
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Immunotherapy
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
6.5 Hormonal Therapy
- 6.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Outpatient Oncology Infusion Market, By Mode

7.1 Key segment trends
7.2 Intramuscular (IM)
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
7.3 Intravenous (IV)
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
7.4 Subcutaneous
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
7.5 Others
- 7.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 8 Outpatient Oncology Infusion Market, By Region

8.1 Key regional trends
8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
  - 8.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.2.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.2.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.2.7 Canada
  - 8.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.2.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.2.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.2.7.4 Market size, by mode, 2017 - 2030 (USD Million)
8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.6 Germany
  - 8.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.3.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.3.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.7 UK
  - 8.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.3.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.3.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.8 France
  - 8.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.3.8.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.3.8.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.9 Spain
  - 8.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.3.9.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.3.9.4 Market size, by mode, 2017 - 2030 (USD Million)
8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.6 Japan
  - 8.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.4.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.4.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.7 China
  - 8.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.4.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.4.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.8 India
  - 8.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.4.8.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.4.8.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.9 Australia
  - 8.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.4.9.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.4.9.4 Market size, by mode, 2017 - 2030 (USD Million)
8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
  - 8.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.5.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.5.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
  - 8.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.5.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.5.7.4 Market size, by mode, 2017 - 2030 (USD Million)
8.6 MEA
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by mode, 2017 - 2030 (USD Million
- 8.6.6 South Africa
  - 8.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.6.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.6.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
  - 8.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
  - 8.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
  - 8.6.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
  - 8.6.7.4 Market size, by mode, 2017 - 2030 (USD Million)

Chapter 9 Company Profiles

9.1 Strategy dashboard, 2021
9.2 B. Braun Melsungen AG
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
9.3 Baxter
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
9.4 Becton, Dickinson, and Company
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
9.5 Fresenius Kabi
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
9.6 ICU Medical, Inc
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
9.7 IRadimed Corporation
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
9.8 Nipro Corporation
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
9.9 Terumo Corporation
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
9.10 Smiths Medical
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
9.11 Medtronic PLC
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
9.12 Roche Diagnostics
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
9.13 Teleflex, Inc.,
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis

癌患者外来輸液の市場規模・シェア・産業分析 (2022-2030年)：製品・用途・療法・モード・地域別の展望・成長の潜在性・競合市場シェア・予測

Outpatient Oncology Infusion Market Size, Share and Industry Analysis Report by Product, Application, By Therapy and Mode (Intramuscular, Intravenous, Subcutaneous), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2030

目次

第1章調査手法

第2章エグゼクティブサマリー

第3章癌患者外来輸液産業の考察

第4章癌患者外来輸液市場：製品別

第5章癌患者外来輸液市場：用途別

第6章癌患者外来輸液市場：療法別

第7章癌患者外来輸液市場：モード別

第8章癌患者外来輸液市場：地域別

第9章企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology

Chapter 2 Executive Summary

Chapter 3 Outpatient Oncology Infusion Industry Insights

Chapter 4 Outpatient Oncology Infusion Market, By Product

Chapter 5 Outpatient Oncology Infusion Market, By Application

Chapter 6 Outpatient Oncology Infusion Market, By Therapy

Chapter 7 Outpatient Oncology Infusion Market, By Mode

Chapter 8 Outpatient Oncology Infusion Market, By Region

Chapter 9 Company Profiles

癌患者外来輸液の市場規模・シェア・産業分析 (2022-2030年)：製品・用途・療法・モード・地域別の展望・成長の潜在性・競合市場シェア・予測

Outpatient Oncology Infusion Market Size, Share and Industry Analysis Report by Product, Application, By Therapy and Mode (Intramuscular, Intravenous, Subcutaneous), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2030

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 癌患者外来輸液産業の考察

第4章 癌患者外来輸液市場：製品別

第5章 癌患者外来輸液市場：用途別

第6章 癌患者外来輸液市場：療法別

第7章 癌患者外来輸液市場：モード別

第8章 癌患者外来輸液市場：地域別

第9章 企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology

Chapter 2 Executive Summary

Chapter 3 Outpatient Oncology Infusion Industry Insights

Chapter 4 Outpatient Oncology Infusion Market, By Product

Chapter 5 Outpatient Oncology Infusion Market, By Application

Chapter 6 Outpatient Oncology Infusion Market, By Therapy

Chapter 7 Outpatient Oncology Infusion Market, By Mode

Chapter 8 Outpatient Oncology Infusion Market, By Region

Chapter 9 Company Profiles

第1章調査手法

第2章エグゼクティブサマリー

第3章癌患者外来輸液産業の考察

第4章癌患者外来輸液市場：製品別

第5章癌患者外来輸液市場：用途別

第6章癌患者外来輸液市場：療法別

第7章癌患者外来輸液市場：モード別

第8章癌患者外来輸液市場：地域別

第9章企業プロファイル